Glioblastoma trials in United Kingdom
20 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 2RecruitingTrial-stage medicine
Irinotecan-ChemoSeed in Surgically Resectable Glioblastoma
- Where
- Birmingham
- Age
- 18 years and over
- People
- 147
- Run by
- CRISM Therapeutics LTD
See details and how to joinNCT07356973Registry updated 2026-11-09
Phase 1RecruitingTrial-stage medicine
Anti-GD2 ADC M3554 in Advanced Solid Tumors
- Where
- Sutton
- Age
- 18 years and over
- People
- 65 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT06641908EU 2024-513687-26-00Registry updated 2026-11-05
Phase 1/2RecruitingTrial-stage medicine
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Where
- Manchester, Sutton
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Bayer
See details and how to joinNCT06914128EU 2025-520623-24-00Registry updated 2026-10-28
Phase 1/2RecruitingTrial-stage medicine
Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma
- Where
- Edinburgh
- Age
- 18 years to 70 years
- People
- 68 worldwide
- Run by
- Trogenix ltd
See details and how to joinNCT07346144Registry updated 2026-10-23
Phase 1/2RecruitingTrial-stage medicine
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Where
- Birmingham, Cardiff, Glasgow, Liverpool, London
- Age
- Up to 25 years
- People
- 75 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610EU 2023-506464-14-00Registry updated 2026-09-25
No phaseRecruitingResearch participation
Targeted Pediatric High-Grade Glioma Therapy
- Where
- London
- Age
- 12 months to 39 years
- People
- 350 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05839379Registry updated 2026-09-08
No phaseRecruitingResearch participation
Surgery and Laser Interstitial Thermal Therapy for Bilateral Glioblastomas
- Where
- London
- Age
- 18 years to 80 years
- People
- 12
- Run by
- King's College Hospital NHS Trust
See details and how to joinNCT07384884Registry updated 2026-09-03
Phase 2RecruitingTrial-stage medicine
Study of Olutasidenib and Temozolomide in HGG
- Where
- London
- Age
- 12 years to 39 years
- People
- 60 worldwide
- Run by
- Rigel Pharmaceuticals
See details and how to joinNCT06161974Registry updated 2026-09-01
Phase 1Not yet recruitingTrial-stage medicine
Human ADME Study of [14C]-AZD1390
- Where
- Guildford, Liverpool
- Age
- 18 years to 99 years
- People
- 8
- Run by
- AstraZeneca
See details and how to joinNCT07643870Registry updated 2026-06-12
No phaseEnrolling by invitationResearch participation
Triggered Imaging in Glioblastoma Based on Clinical Outcome Evaluation Compared to Routine: a Feasibility Study
- Where
- London
- Age
- 18 years and over
- People
- 20
- Run by
- King's College Hospital NHS Trust
See details and how to joinNCT07634575Registry updated 2026-06-09
Phase 2RecruitingTrial-stage medicine
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Where
- London
- Age
- 12 months to 39 years
- People
- 120 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05843253Registry updated 2026-05-29
No phaseRecruitingResearch participation
Preoperative Preradiotherapy TTFields
- Where
- Manchester
- Age
- 35 years and over
- People
- 42
- Run by
- The Christie NHS Foundation Trust
See details and how to joinNCT06136611Registry updated 2026-05-08
No phaseNot yet recruitingResearch participation
MRinRT: Swansea University and SWWCC Collaboration Study.
- Where
- Swansea
- Age
- 18 years and over
- People
- 165
- Run by
- Swansea Bay University Health Board
See details and how to joinNCT07365124Registry updated 2026-04-30
No phaseNot yet recruitingResearch participation
FCI-Glioblastoma Study
- Where
- Aberdeen
- Age
- 18 years to 70 years
- People
- 18
- Run by
- University of Aberdeen
See details and how to joinNCT07443176Registry updated 2026-04-30
Phase 1RecruitingTrial-stage medicine
A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.
- Where
- London
- Age
- 18 years and over
- People
- 16
- Run by
- University College, London
See details and how to joinNCT07134842Registry updated 2026-04-09
Phase 1/2RecruitingTrial-stage medicine
5G-PEARL: Paxalisib in Malignant Brain Tumours
- Where
- Sutton
- Age
- 16 years and over
- People
- 64
- Run by
- Institute of Cancer Research, United Kingdom
See details and how to joinNCT07391215Registry updated 2026-02-05
Phase 1/2RecruitingTrial-stage medicine
5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
- Where
- Cambridge, Sutton
- Age
- 16 years and over
- People
- 182
- Run by
- Institute of Cancer Research, United Kingdom
See details and how to joinNCT06630260Registry updated 2026-01-21
No phaseRecruitingResearch participation
The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
- Where
- Cambridge, London
- Age
- 40 years to 75 years
- People
- 6,000 worldwide
- Run by
- Javier Toledo
See details and how to joinNCT06717295Registry updated 2026-01-02
Phase 2RecruitingTrial-stage medicine
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- London, Manchester, Surrey Quays
- Age
- 18 years and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224EU 2024-514542-37-00Registry updated 2025-06-27
No phaseRecruitingResearch participation
Ex VIvo DEtermiNed Cancer Therapy
- Where
- Sheffield
- Age
- 16 years and over
- People
- 600
- Run by
- Sheffield Teaching Hospitals NHS Foundation Trust
See details and how to joinNCT05231655Registry updated 2025-02-24
All Glioblastoma trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.